News for 'drug quality'

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

'Maligning the medical fraternity was not expected of PM'

'Maligning the medical fraternity was not expected of PM'

Rediff.com22 Apr 2018

The Indian Medical Association and the Mumbai Association of Medical Consultant have written a letter to Narendra Modi expressing disappointment over his statement during the Bharat ki Baat Sabke saath event in London.

India likely to have Covid vaccine in new year: DCGI

India likely to have Covid vaccine in new year: DCGI

Rediff.com31 Dec 2020

The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.

Why Chinese imports are likely to continue

Why Chinese imports are likely to continue

Rediff.com26 Jun 2020

Indian auto and pharma industries import several critical components and raw materials from China.

Ankylosing Spondylitis: The back pain that should alarm young India

Ankylosing Spondylitis: The back pain that should alarm young India

Rediff.com8 Jan 2018

Nearly 30 to 40 lakh people in India suffer from Ankylosing Spondylitis.

US gives full approval to Pfizer Covid vaccine

US gives full approval to Pfizer Covid vaccine

Rediff.com23 Aug 2021

More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Rediff.com9 Jun 2021

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of Covaxin.

Qualities that will help a leader tide over crisis

Qualities that will help a leader tide over crisis

Rediff.com7 Apr 2014

During a crisis situation, effective communication both internally and externally is one of the most important measures.

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Rediff.com24 May 2021

Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) has begun the production of 'Sputnik V' COVID-19 vaccine in India, according to a joint statement issued.

Delta plus: New Covid variant identified in India

Delta plus: New Covid variant identified in India

Rediff.com14 Jun 2021

The highly transmissible Delta variant of SARS-CoV-2 has mutated further to form the 'Delta plus' or 'AY.1' variant but there is no immediate cause for concern in India as its incidence in the country is still low, scientists in New Delhi said.

Does India have enough jabs to expand vaccination drive?

Does India have enough jabs to expand vaccination drive?

Rediff.com3 Jan 2022

A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.

India's COVID-19 fatality rate slides to 1.76%: Govt

India's COVID-19 fatality rate slides to 1.76%: Govt

Rediff.com2 Sep 2020

As many as 1,578 dedicated COVID hospitals are providing quality medical care.

What is the future of e-pharmacies in India?

What is the future of e-pharmacies in India?

Rediff.com19 Dec 2019

PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.

Lapses by some pharma cos overshadowed good things: FDA chief

Lapses by some pharma cos overshadowed good things: FDA chief

Rediff.com12 Feb 2014

On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.

Darlings Is Daring, Not Superficial

Darlings Is Daring, Not Superficial

Rediff.com12 Aug 2022

I cannot think of another Hindi movie that has, without so much as a hint of cynicism or speechifying, brought out that fundamental fact of Muslims being an integral part of the Indian culture while being at the same time a subculture with its own polite niceties, observes Sreehari Nair.

Wockhardt told to pull out analgesic batches

Wockhardt told to pull out analgesic batches

Rediff.com14 Feb 2013

Regulator mentions Wockhardt as manufacturer but firm says it only markets drug.

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Rediff.com7 Apr 2014

Sun Pharmaceutical said Ranbaxy shareholders will get 0.8 Sun Pharma shares for each Ranbaxy share.

Now, bar coding mandatory for pharma exports

Now, bar coding mandatory for pharma exports

Rediff.com13 Jan 2011

The commerce ministry has mandated bar coding on all medicine packs meant for exports from July 1, to trace and track these medicines to its source of origin. The move is in response to quality concerns raised against Indian drugs by some African countries.

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Rediff.com14 Apr 2020

As its factories resumed operations after over two-month of grim battle against coronavirus, China is busy tapping into the vast business opportunities of export of key medical goods, specially ventilators and personal protection equipment (PPE), across the world, including India, where both private and government bodies are placing orders for the import of these products.

Company Watch: Emami, Shriram Transport, Lupin

Company Watch: Emami, Shriram Transport, Lupin

Rediff.com8 Feb 2021

Check out some of the stocks that will react on the basis of their numbers in the near term.

Scientists urge caution over launch of Covid vaccine by Aug 15

Scientists urge caution over launch of Covid vaccine by Aug 15

Rediff.com4 Jul 2020

'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'

Bharat Biotech, Serum Institute to jointly roll out vaccines

Bharat Biotech, Serum Institute to jointly roll out vaccines

Rediff.com5 Jan 2021

In a joint statement posted on their respective twitter accounts, the companies said Serum Institute Chief Executive Officer Adar Poonawalla and Bharat Biotech Chairman Krishna Ella communicated their combined intent to develop, manufacture and supply the COVID-19 vaccines.

Conmen cash in on Covid desperation amid 2nd wave

Conmen cash in on Covid desperation amid 2nd wave

Rediff.com18 May 2021

At a time when the country's medical infrastructure has become incapable of handling the pressure of Covid's deadly second wave, a parallel wave of conmen, black marketers and counterfeiters can be witnessed across the country. Geetanjali Krishna reports.

SC decision on Novartis to benefit poor: Pharma cos

SC decision on Novartis to benefit poor: Pharma cos

Rediff.com1 Apr 2013

Terming the judgement as a 'landmark judgement' in favour of poor patients, domestic drug manufacturer associations, including Indian Pharmaceutical Alliance and Indian Drug Manufacturers' Association, hailed the apex court's decision.

How safe are medicines made in India?

How safe are medicines made in India?

Rediff.com14 Apr 2014

Patients have become wary of India-made drugs after a number of reports highlighted their substandard quality.

Cap on stent prices brings Chinese maker to India

Cap on stent prices brings Chinese maker to India

Rediff.com28 Feb 2017

MicroPort entered the market on Feb 15 and its stent was used in a Mumbai hospital.

The WORST FILMS of 2021

The WORST FILMS of 2021

Rediff.com1 Jan 2022

Every year, with the good, there are bad movies too.

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

Can Ranbaxy come out of the shadows?

Can Ranbaxy come out of the shadows?

Rediff.com5 Jul 2013

It has hired consultants to advise it on a strategic project and compliance issues in the US. It also needs to improve employee morale.

10 Reasons Why Men FAIL at SEX

10 Reasons Why Men FAIL at SEX

Rediff.com6 May 2021

Men tend to consider sex as a way to impress their partner. When they give this thinking a great deal of importance, it turns into what is generally called performance anxiety, cautions Rajat Jadhav

Pharma sector in alarm over govt's cure

Pharma sector in alarm over govt's cure

Rediff.com28 Oct 2017

The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.

Covid vaccine possible by 2021 first quarter: Vardhan

Covid vaccine possible by 2021 first quarter: Vardhan

Rediff.com13 Sep 2020

Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.

Dr Reddy's sued in US court by S Korean pharma co

Dr Reddy's sued in US court by S Korean pharma co

Rediff.com27 Jan 2017

Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator.

We are safe only when everyone is safe

We are safe only when everyone is safe

Rediff.com7 Jul 2021

So vaccinate employees and families, staff at home, rickshaw drivers, milkmen, service providers, shopkeepers and street vendors, says Naushad Forbes.

How India's pharma growth story fizzled out

How India's pharma growth story fizzled out

Rediff.com5 Jul 2017

Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.

Regulator finds procedural lapses at Wockhardt's US facility

Regulator finds procedural lapses at Wockhardt's US facility

Rediff.com3 Jun 2014

The FDA had imposed a ban on the company's Waluj plant in May.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

India, Canada to tap pharma opportunities

India, Canada to tap pharma opportunities

Rediff.com23 Nov 2007

The drug regulatory agencies of India and Canada are planning to collaborate on improving the quality of drugs traded between the two countries, besides helping the industry in both the countries to tap the opportunities in the field of generic medicines and drug development.

The BEST and WORST of 2021

The BEST and WORST of 2021

Rediff.com3 Jan 2022

A year marked by more lows than highs for Hindi cinema, here's a recap of the best and worst in 2021.

Answered: When COVID-19 will end

Answered: When COVID-19 will end

Rediff.com24 Jul 2020

'"The end" depends on two things.' 'Either you develop a vaccine which is effective or if you have a drug, you can terminate this infection very quickly.' 'Otherwise, you have to depend on herd immunity.' 'I think it should happen earlier. Far earlier, than we can imagine or achieve 'herd immunity'.'